Open original FDA record ↗Recall record
- FDA identifier
- Z-0583-2012
- Company in FDA record
- Ino Therapeutics
- FDA classification date
- Jan 11, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Through the review and monitoring of its complaint data, Ikaria identified a product anomaly with the INOmax DS Model 1003. Ikaria concluded the anomaly risk to the patient safety was low and non reportable (4/23/10). During a subsequent Level 3 inspection by FDA, it was concluded that the action should have been reported under 21 CFR & 806.10.
Source facts
- Action
- Ikaria sent a "RECALL- CUSTOMER PRODUCT REMEDIATION" notice dated December 22, 2011 to all affected customers. The letter describes the product, problem, actions taken by the firm. No action was required by customers. The notice served as correspondence to inform customers of the issue. Customers may direct their questions to Ikaria Customer Care at 1-877-566-9466.
- Initiated
- 2010-11-30
- Root cause
- Nonconforming Material/Component
- Terminated
- 2012-05-29
- Distribution
- Worldwide Distribution-USA (nationwide) and the country of MALAYSIA.
- Recall number
- Z-0583-2012
- Recall status
- Terminated
- CDRH record ID
- 104896
- FDA classified
- 2012-01-11
- Recall event number
- 60258